AlvaroKohn Profile Banner
Alvaro Köhn-Luque Profile
Alvaro Köhn-Luque

@AlvaroKohn

Followers
1K
Following
9K
Media
221
Statuses
2K

Senior scientist @OCBE_UniOslo, mathematician working on personalized cancer medicine using mechanistic modeling, machine leaning or combinations of both.

Oslo, Noruega
Joined February 2016
Don't wanna be here? Send us removal request.
@AlvaroKohn
Alvaro Köhn-Luque
1 year
I am transitioning from dark to blue skies 🦋 and I will shortly close this account. I hope to see you in the other side 🙌
0
0
4
@OCBE_UniOslo
Oslo Centre for Biostatistics and Epidemiology
1 year
OCBE is transitioning from dark to blue skies 🦋 and we will shortly close this account. We hope to see you in the other side 🙌
1
1
6
@AlvaroKohn
Alvaro Köhn-Luque
1 year
Don’t miss this great summary of our latest preprint
@YounessAzimzade
Youness Azimzade
1 year
If you are interested in immune cells in tumors and their impact on clinical outcomes, our latest work might interest you: https://t.co/1dMjV63utd. We pose a simple question: how is the abundance of different cell types associated with treatment response and relapse? 1/n
0
1
3
@BIRS_Math
BIRS
1 year
Leah Edelstein-Keshet (University of British Columbia), Modeling & simulating single cell motility optogenetic experiments
0
1
3
@VivliCenter
Vivli
1 year
Congratulations to @MyelomaOslo on your public disclosure, “Relapse prediction in multiple myeloma patients treated with isatuximab, carfilzomib, and dexamethasone.” We’re proud to facilitate your access to data #ClinicalResearch
Tweet card summary image
medrxiv.org
Multiple myeloma (MM) patients experience repeated cycles of treatment response and relapse, yet despite close monitoring of disease status through M protein measurements, no standard model exists...
0
1
1
@RESCUER2020
RESCUER
1 year
Mads Haugen presenting at Lewis-Sigler institute work from his group and RESCUER @YounessAzimzade @AlvaroKohn @freeges
0
1
5
@christophertape
Chris Tape
1 year
Excellent review from @mariangelaruss2 @BardelliLab discussing our current understanding of drug-tolerant persister cells in cancer. https://t.co/iBDEuhZMgs
0
12
39
@Bartomeu_Colom
Bartomeu Colom
1 year
'Mechanisms that clear mutations drive field cancerization in mammary tissue' https://t.co/8L7BfInxu2
0
8
45
@mathoncoblog
Mathoncoblog
1 year
Just on time for labor day weekend (for those of you State-side) @mathoncbro writes about mechanistic learning, the best of two worlds based on a paper by @jmetzcar @MathCancer @AlvaroKohn @Jutzeler_Cathy and Sara Bruningk: https://t.co/w2t0Gk0ViA #MachineLearning #MathOnco
Tweet card summary image
mathematical-oncology.org
The Mathematical Oncology Community Resource
0
6
14
@ara_anderson
Sandy Anderson
1 year
Excited to share the fruits of a new collaboration with @AguadeGuim and @ricard_sole on: Modeling tumors as complex ecosystems. This perspective is open access with almost 230 references - out now in @iScience_CP https://t.co/eIXAHY3fiZ
2
24
122
@OxUniMaths
Oxford Mathematics
1 year
Oxford Mathematician and Fellow of @StJohnsOx Philip Maini has been awarded the Sylvester Medal by the @royalsociety for his contributions to mathematical biology. Pretty good teacher too. https://t.co/On8KkwubXl Photo: Robert Taylor/St John's
14
41
230
@AlvaroKohn
Alvaro Köhn-Luque
1 year
Don’t miss these remarks of our review paper by the amazing @mathoncbro 🙌 thank you 🙏 @OCBE_UniOslo #mathonco
@mathoncbro
Jeffrey West
1 year
This paper has my vote for Most Interesting & Provocative new ideas in "philosophy of modeling" in the last several years: https://t.co/cim0zqNqkg My summary: 🧵🧵🧵
0
1
17
@NikoMcCarty
Niko McCarty.
1 year
30 Essays to Make You Love Biology Day 1. "I should have loved biology" by James Somers. "It was only in college, when I read Douglas Hofstadter’s Gödel, Escher, Bach, that I came to understand cells as recursively self-modifying programs."
11
170
922
@StolzBernadette
Dr. Bernadette Stolz
1 year
Great first day at #ECMTB24 including interesting talks on integrating mechanistic models and machine learning in mathematical oncology by @guillelorenzogz and @SBruningk.
1
1
18
@pejmanshojam31
Pejman Shojaee
1 year
Attended to the first session „mechanistic learning in mathematical oncology“ organised by @AlvaroKohn. Babis @M3sBiomath gave his talk on making clinical predictions without understanding everything. @ecmtb2024 #Toledo #math_onco
0
2
15
@ecmtb2024
ECMTB 2024
1 year
Dear ECMTB2024 participants, The 13th Edition of the European Conference on Mathematical and Theoretical Biology https://t.co/YBMm9BXYCk is just around the corner so, before arriving in Toledo, we would like to give you some indications. 🧵(1/10)
1
2
16
@CCR_AACR
Clinical Cancer Research
1 year
Read the article: Computational model predicts patient outcomes in Luminal B breast cancer treated with endocrine therapy and CDK4/6 inhibition. https://t.co/2uUkRVbyMu
@AlvaroKohn
Alvaro Köhn-Luque
1 year
Thanks for highlighting our recent @CCR_AACR paper predicting patient outcomes in breast cancer treated with endocrine therapy and CDK4/6 inhibition. Also really looking forward to read the ctDNA paper of #JasmineFoo et al. And congratulations on the 300 #MathOnco edition!
0
2
6
@AlvaroKohn
Alvaro Köhn-Luque
1 year
Thanks for highlighting our recent @CCR_AACR paper predicting patient outcomes in breast cancer treated with endocrine therapy and CDK4/6 inhibition. Also really looking forward to read the ctDNA paper of #JasmineFoo et al. And congratulations on the 300 #MathOnco edition!
@mathoncbro
Jeffrey West
1 year
This week in #MathOnco 300! ecological interactions, predictive modeling, CT DNA kinetics, and more... Art: Artist: Mark Chaplain (@mcapellanus), Nikos Sfakianakis, Dimitris Katsaounis, Nicholas Harbour, Thomas Williams Signup: https://t.co/RASvJNgCF4
0
1
8
@AlvaroKohn
Alvaro Köhn-Luque
1 year
This is a @RESCUER2020 project led by our own @l_schmiester @OCBE_UniOslo and involving @prat_aleix @Vesselinka @freeges @fara_bm @XahTekK @TomasPascualMD #JürgenGeisler etc. We’d be very happy to collaborate with anybody interested in validating or testing our model further.
0
2
2
@AlvaroKohn
Alvaro Köhn-Luque
1 year
Is our #mathonco modeling clinically relevant? Check our brand new paper @CCR_AACR describing a mathematical model that predicts outcomes in breast cancer patients treated with endocrine therapy and cdk4/6 inhibitors. https://t.co/Rf1AAAKzdQ
5
7
26